Deadline extended to apply for vacancies on UK NSC expert groups
We've extended the deadline to apply for one of the 12 vacancies on the UK NSC's expert groups to Friday, 21 April 2023.
Search results for about
Assessing the evidence for using multi-cancer early detection tests in screening
Multi-cancer early detection tests, which hold out the hope of detecting dozens of cancers before symptoms emerge, present a major but exciting new challenge for the UK National Screening Committee and its processes for reviewing evidence.
Experts discuss models for personalised breast screening based on risk
The UK's independent expert screening committee organised a risk stratification modelling event for researchers to showcase their work and outline possible improvements to the NHS Breast Screening Programme.
Exciting opportunities to join one of the UK NSC’s expert groups
Apply for one of 12 exciting vacancies in the expert reference groups that support the UK National Screening Committee.
Engaging with industry gives fascinating insight into potential of multi-condition tests for screening
Twelve companies from around the world attended a UK National Screening Committee virtual event to share information on the development of multi-cancer early detection tests and how these tests might eventually lead to exciting developments in the UK’s cancer screening programmes.
Simple screening comparisons between countries mask complex differences
Variation in how health services are delivered and funded, how screening is described and how screening policy is made help explain differences between countries and regions in what conditions they screen for.
UK NSC recommends introduction of screening for tyrosinaemia in newborns
The UK National Screening Committee is recommending the introduction of screening for tyrosinaemia as part of the newborn blood spot screening programme.
UK NSC receives record number of annual call screening proposals
The UK National Screening Committee (UK NSC) received a record number of 29 proposals during its 2022 annual call for topics. This is by far the most submissions it has received in a single year since the annual call process started in 2016.
UK NSC public engagement on genome sequencing wins prestigious award
A public dialogue on the implications of whole genome sequencing (WGS) for newborn screening, commissioned by the UK NSC, has won the 2022 Market Research Society (MRS) award for public policy/social research.
Work starts on reviewing the case for screening for SMA
Researchers start work on new project to review evidence for newborn screening for spinal muscular atrophy.